Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucatumumab in advanced Non-Hodgkin's or Hodgkin's Lymphoma
NCT00670592Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Feb 2013
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 2 trial of lucatumumab in Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Novartis. Started Mar 2008; status: completed.
02
Drugs
lucatumumab
03
Conditions
Non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00670592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670592.